Bukwang Pharmaceutical Co., Ltd.(KR:003000)
₩3,985.00+35.00 (+0.89%)
KR:003000
Bukwang Pharmaceutical Co., Ltd. financials statements
₩3,985.00
At close:+35.00 (+0.89%)
Want to see KR:003000 full AI Analyst Report?
Bukwang Pharmaceutical Co., Ltd. (003000) Income Statement
Bukwang Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Bukwang Pharmaceutical Co., Ltd.'s total revenue was ₩56.99B, an increase of 33.84% from the same quarter last year. In Q2, Bukwang Pharmaceutical Co., Ltd.'s net income was ₩1.40B. See Bukwang Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 200.71B | ₩ 160.09B | ₩ 125.93B | ₩ 190.91B | ₩ 182.49B | |
| ₩ 95.72B | ₩ 74.34B | ₩ 50.05B | ₩ 79.43B | ₩ 75.76B | |
| ₩ 81.56B | ₩ 72.73B | ₩ 87.54B | ₩ 79.66B | ₩ 70.14B | |
| Depreciation and Amortization | ₩ 5.49B | ₩ 4.11B | ₩ 4.29B | ₩ 5.12B | ₩ 4.84B |
| ₩ 19.65B | ₩ 7.63B | ₩ -31.47B | ₩ 4.89B | ₩ 11.40B | |
| ₩ 14.16B | ₩ 1.62B | ₩ -37.50B | ₩ -230.64M | ₩ 5.62B | |
| ₩ -7.78B | ₩ -4.59B | ₩ -2.07B | ₩ -802.24M | ₩ -1.83B | |
| ₩ 6.39B | ₩ -2.97B | ₩ -39.57B | ₩ -1.03B | ₩ 3.79B | |
| ₩ 12.57B | ₩ -2.64B | ₩ -31.33B | ₩ -2.47B | ₩ -916.62M | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 152.00 | ₩ -38.59 | ₩ -458.00 | ₩ -36.15 | ₩ -13.39 |
| Diluted EPS | ₩ 152.00 | ₩ -38.59 | ₩ -457.67 | ₩ -36.15 | ₩ -13.39 |
| Weighted Average Shares Outstanding | 98.67M | 68.45M | 68.41M | 68.45M | 68.46M |
| Weighted Average Shares Outstanding (Diluted) | 98.67M | 68.45M | 68.45M | 68.45M | 68.46M |
Currency in KRW

